oridonin and Colitis

oridonin has been researched along with Colitis* in 1 studies

Other Studies

1 other study(ies) available for oridonin and Colitis

ArticleYear
Discovery of 4-((E)-3,5-dimethoxy-2-((E)-2-nitrovinyl)styryl)aniline derivatives as potent and orally active NLRP3 inflammasome inhibitors for colitis.
    European journal of medicinal chemistry, 2022, Jun-05, Volume: 236

    NLRP3 inflammasome activation plays a key role in a variety of inflammatory diseases as IBD. Here a series of pterostilbene derivatives were designed and synthesized based on previous SAR, leading to discovery of new effective NLRP3 inflammasome inhibitors with metabolic stability. Among them, the most effective compound 27 showed high inhibitory efficacy (against IL-1 β: IC

    Topics: Aniline Compounds; Animals; Cell Line; Colitis; Inflammasomes; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein

2022